hydromorphone has been researched along with butorphanol in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (29.03) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 9 (29.03) | 29.6817 |
| 2010's | 6 (19.35) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Kotick, MP; Leland, DL | 2 |
| Howes, JF; Kotick, MP; Osgood, PF; Polazzi, JO; Razdan, RK; Schut, RN; Villarreal, JE | 1 |
| Bousquet, AR; Howes, JF; Kotick, MP; Leland, DL; Polazzi, JO | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bigelow, GE; Liebson, IA; Preston, KL | 3 |
| Bickel, W; Bigelow, G; Liebson, I; Preston, K | 1 |
| Bickel, WK; Bigelow, GE; Liebson, IA; Preston, KL | 1 |
| Blake, JW; Combie, J; Nugent, TE; Tobin, T | 1 |
| Bigelow, GE; Preston, KL | 1 |
| Barta, PE; Bigelow, GE; Greenberg, BD; Lancaster, E; Pearlson, GD; Preston, KL; Schlaepfer, TE; Strain, EC | 1 |
| Bigelow, GE; Jones, HE; Preston, KL | 1 |
| Gregg, T; Gunter, JB; McAuliffe, J; Sweeney, DM; Varughese, AM; Weidner, N | 1 |
| Abreu, ME; Bigelow, GE; Strain, EC; Walsh, SL | 1 |
| David Clark, J; Demirci, H; Gharagozlou, P; Lameh, J | 1 |
| Campbell, VL; Drobatz, KJ; Perkowski, SZ | 1 |
| Keegan, RD; Kuo, WC | 1 |
| Erb, HN; Gleed, RD; Goldstein, RE; Ludders, JW; Posner, LP; Simpson, KW; Smith, AA | 1 |
| Abbo, LA; Inoue, T; Johnson, BM; Ko, JC; Payton, ME; Weil, AB | 1 |
| Austin, BR; Barletta, M; Ko, JC; Krimins, RA; Payton, ME; Weil, AB | 1 |
| Defarges, A; Naigamwalla, DZ; Rosati, M; Webb, JA | 1 |
| Baetge, CL; Coursey, CD; Lizarraga, I; Scallan, EM; Simon, BT | 1 |
| Browning, DC; DeGroot, WD; Tobias, KM; Zhu, X | 1 |
| Barletta, M; Chang, K; Ishikawa, Y; Knych, H; Quandt, J; Reed, R; Sakai, D; Skrzypczak, H; Trenholme, N | 1 |
| Gong, X; Xie, S; Zhang, G; Zhang, Y | 1 |
1 review(s) available for hydromorphone and butorphanol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 trial(s) available for hydromorphone and butorphanol
| Article | Year |
|---|---|
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Topics: Adult; Butorphanol; Cognition; Double-Blind Method; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Substance Withdrawal Syndrome | 1988 |
Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects.
Topics: Amygdala; Brain; Butorphanol; Cerebrovascular Circulation; Double-Blind Method; Emotions; Euphoria; Gyrus Cinguli; Humans; Hydromorphone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Placebos; Receptors, Opioid; Regional Blood Flow; Technetium Tc 99m Exametazime; Temporal Lobe; Thalamus; Tomography, Emission-Computed, Single-Photon | 1998 |
Continuous epidural butorphanol relieves pruritus associated with epidural morphine infusions in children.
Topics: Adolescent; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Antipruritics; Bupivacaine; Butorphanol; Chi-Square Distribution; Child; Child, Preschool; Consciousness; Cross-Over Studies; Diphenhydramine; Double-Blind Method; Follow-Up Studies; Histamine H1 Antagonists; Humans; Hydromorphone; Incidence; Injections, Epidural; Morphine; Pain Measurement; Pain, Postoperative; Prospective Studies; Pruritus | 2000 |
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Benzofurans; Butorphanol; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heroin Dependence; Humans; Hydromorphone; Male; Middle Aged; Neuroprotective Agents; Pilot Projects; Pyrrolidines; Receptors, Opioid, kappa | 2001 |
Effect of orally administered tramadol alone or with an intravenously administered opioid on minimum alveolar concentration of sevoflurane in cats.
Topics: Administration, Inhalation; Administration, Oral; Analgesics, Opioid; Anesthetics, Inhalation; Animals; Blood Gas Analysis; Butorphanol; Cats; Cross-Over Studies; Drug Combinations; Drug Interactions; Female; Hydromorphone; Male; Methyl Ethers; Pulmonary Alveoli; Sevoflurane; Tramadol | 2008 |
Evaluation of dexmedetomidine and ketamine in combination with various opioids as injectable anesthetic combinations for castration in cats.
Topics: Anesthesia Recovery Period; Anesthesia, Intravenous; Anesthetics, Combined; Animals; Blood Pressure; Buprenorphine; Butorphanol; Cats; Dexmedetomidine; Heart Rate; Hydromorphone; Ketamine; Male; Orchiectomy | 2011 |
The use of medetomidine-based sedation protocols to perform urohydropropulsion and cystoscopy in the dog.
Topics: Animals; Butorphanol; Cystoscopy; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Hydromorphone; Hypnotics and Sedatives; Male; Medetomidine; Urologic Diseases | 2014 |
The antinociceptive effects of intravenous administration of three doses of butorphanol tartrate or naloxone hydrochloride following hydromorphone hydrochloride to healthy conscious cats.
Topics: Administration, Intravenous; Analgesics, Opioid; Animals; Butorphanol; Cats; Cross-Over Studies; Drug Therapy, Combination; Female; Hydromorphone; Naloxone; Pain; Pain Measurement; Random Allocation; Skin Temperature | 2019 |
Comparison of hydromorphone and butorphanol for management of pain in equine patients undergoing elective arthroscopy: a randomized clinical trial.
Topics: Analgesics, Opioid; Animals; Arthroscopy; Butorphanol; Horses; Hydromorphone; Pain; Pain Measurement | 2022 |
21 other study(ies) available for hydromorphone and butorphanol
| Article | Year |
|---|---|
Analgesic narcotic antagonists. 5. 7,7-Dimethyldihydrocodeinones and 7,7-dimethyldihydromorphinones.
Topics: Analgesics, Opioid; Animals; Codeine; Hydrocodone; Hydromorphone; Mice; Narcotic Antagonists; Rats; Structure-Activity Relationship | 1981 |
Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones.
Topics: Acetates; Analgesics; Animals; Haplorhini; Humans; Mice; Morphinans; Morphine Dependence; Narcotic Antagonists; Rats; Reaction Time; Structure-Activity Relationship; Substance Withdrawal Syndrome; Substance-Related Disorders | 1980 |
Analgesic narcotic antagonists. 4. 7-Methyl-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Humans; Morphinans; Morphine Dependence; Narcotic Antagonists; Substance Withdrawal Syndrome | 1980 |
Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Hydrocodone; In Vitro Techniques; Mice; Narcotic Antagonists; Rats; Reaction Time | 1981 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discrimination of butorphanol and nalbuphine in opioid-dependent humans.
Topics: Adult; Behavior; Blood Pressure; Body Temperature; Butorphanol; Discrimination, Psychological; Generalization, Psychological; Humans; Hydromorphone; Male; Methadone; Middle Aged; Nalbuphine; Naloxone; Psychomotor Performance; Pupil; Receptors, Opioid | 1990 |
Butorphanol-precipitated withdrawal in opioid-dependent human volunteers.
Topics: Butorphanol; Heart Rate; Humans; Hydromorphone; Male; Methadone; Morphinans; Naloxone; Opioid-Related Disorders; Pupil; Respiration; Skin Temperature; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1987 |
Drug discrimination in human post-addicts: agonist/antagonist opioids.
Topics: Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Humans; Hydromorphone; Male; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Pentazocine | 1988 |
Drug discrimination in human postaddicts: agonist-antagonist opioids.
Topics: Adult; Buprenorphine; Butorphanol; Conditioning, Operant; Discrimination, Psychological; Humans; Hydromorphone; Male; Nalbuphine; Pentazocine; Pupil; Substance-Related Disorders | 1989 |
Furosemide, Patella vulgata beta-glucuronidase and drug analysis: conditions for enhancement of the TLC detection of apomorphine, butorphanol, hydromorphone, nalbuphine, oxymorphone and pentazocine in equine urine.
Topics: Animals; Apomorphine; Butorphanol; Cattle; Chromatography, Thin Layer; Female; Furosemide; Glucuronidase; Helix, Snails; Horses; Hydrolysis; Hydromorphone; Mollusca; Nalbuphine; Oxymorphone; Pentazocine; Species Specificity | 1982 |
Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
Topics: Adult; Buprenorphine; Butorphanol; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Humans; Hydromorphone; Male; Nalbuphine; Pentazocine; Psychomotor Performance | 1994 |
Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Topics: Adult; Blood Pressure; Buprenorphine; Butorphanol; Choice Behavior; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Hydromorphone; Injections, Intramuscular; Male; Nalbuphine; Pentazocine; Psychomotor Performance; Surveys and Questionnaires | 1999 |
Activity of opioid ligands in cells expressing cloned mu opioid receptors.
Topics: Azocines; beta-Endorphin; Binding, Competitive; Butorphanol; Cell Line; Colforsin; Cyclic AMP; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Etorphine; Fentanyl; Humans; Hydromorphone; Ligands; Morphine; Naltrexone; Phenazocine; Radioligand Assay; Receptors, Opioid, mu; Tritium | 2003 |
Postoperative hypoxemia and hypercarbia in healthy dogs undergoing routine ovariohysterectomy or castration and receiving butorphanol or hydromorphone for analgesia.
Topics: Analgesics, Opioid; Animals; Blood Gas Analysis; Butorphanol; Carbon Dioxide; Dog Diseases; Dogs; Female; Hydromorphone; Hypercapnia; Hypoxia; Hysterectomy; Male; Orchiectomy; Ovariectomy; Oxygen; Partial Pressure; Postoperative Complications | 2003 |
Comparative cardiovascular, analgesic, and sedative effects of medetomidine, medetomidine-hydromorphone, and medetomidine-butorphanol in dogs.
Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics, Opioid; Analysis of Variance; Animals; Blood Gas Analysis; Blood Pressure; Body Temperature; Butorphanol; Cardiac Output; Central Venous Pressure; Dogs; Heart Rate; Hydromorphone; Injections, Intravenous; Medetomidine; Pulmonary Wedge Pressure; Respiration; Stroke Volume; Time Factors; Vascular Resistance | 2004 |
Evaluation of the effects of premedication on gastroduodenoscopy in cats.
Topics: Analgesics; Anesthesia, General; Anesthetics, Combined; Animals; Butorphanol; Cats; Cross-Over Studies; Duodenoscopy; Female; Gastroscopy; Glycopyrrolate; Hydromorphone; Isoflurane; Ketamine; Medetomidine; Parasympatholytics; Preanesthetic Medication; Random Allocation | 2004 |
Examination of laryngeal function of healthy dogs by using sedation protocols with dexmedetomidine.
Topics: Analgesics, Opioid; Animals; Butorphanol; Conscious Sedation; Cross-Over Studies; Dexmedetomidine; Dogs; Hydromorphone; Hypnotics and Sedatives; Larynx; Random Allocation | 2020 |
Analgesic effect of butorphanol tartrate combined with hydromorphone on patients with cesarean section: A prospective cohort study.
Topics: Butorphanol; Cesarean Section; Female; Humans; Hydromorphone; Infant, Newborn; Jaundice, Neonatal; Pain; Pregnancy; Prospective Studies | 2022 |